TWIST BIOSCIENCE CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.75 USD | -2.38% |
|
+7.63% | -16.58% |
Presenter SpeechChris Thorne;Senior Manager, Field Marketing (Executives)Welcome, everyone. Go...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. It has miniaturized traditional chemical DNA synthesis reactions to write over one million short pieces of DNA on each silicon chip. It offers two product lines: synthetic biology tools and NGS tools, that address different needs of its customers across a variety of applications. It offers ribonucleic acid and protein products. Its synthetic biology products include synthetic genes and gene fragments, and oligonucleotide or oligo pools.
Sector
Pharmaceuticals
Calendar
2024-05-01
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
30.75
USD
Average target price
40.25
USD
Spread / Average Target
+30.89%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -16.58% | 1.78B | |
| -2.86% | 87.31B | |
| +3.95% | 40.86B | |
| -21.94% | 29.36B | |
| +53.87% | 24.49B | |
| -5.41% | 17.31B | |
| -44.23% | 11.26B | |
| -17.60% | 11.62B | |
| -13.96% | 11.31B | |
| +4.87% | 8.31B |
- Stock Market
- Equities
- TWST Stock
- News Twist Bioscience Corporation
- Transcript : Twist Bioscience Corporation - Special Call
